When a company ― or anyone on its executive team ― is facing a regulatory inquiry, securities class action, or shareholder derivative suit, maintaining focus on business plans and priorities is challenging. We understand the magnitude of what's at stake. Our powerhouse Securities Litigation team has expertise representing the nation’s leading life sciences, pharmaceuticals, construction, insurance and financial services companies as well as high profile individuals, directors and officers, senior executives, and CEOs in complex securities claims that require a multi-disciplinary bench of attorneys and the ability to resolve matters quietly and without publicity. That’s why clients like Apollo turn to Mintz when their portfolio company M&A activity gives rise to multiple shareholder disputes.
Maintaining a Focus on Your Business
Securities Litigation Guidance and Resources for Public Companies
Co-Chair ranked Band 2 in Massachusetts (2021)
Legal 500 United States
Practice ranked Tier 4 for Securities Litigation- Defense (2021)
U.S. News and Best Lawyers®
Practice ranked National Tier 2, Metropolitan Tier 2 in Boston and New York City, Metropolitan Tier 3 in San Diego, Litigation - Securities, "Best Law Firms" (2021)
Multiple Attorneys Ranked as Litigation Stars (2021)
5 attorneys named Massachusetts Super Lawyers (2020)
35 Litigation attorneys recognized (2020)
What Our Clients Are Saying
Market CommentatorChambers USA (2021)
Our team has defended clients in a broad range of investigations and enforcement actions — ranging from informal inquiries and formal investigations to administrative and judicial enforcement proceedings.